BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2479356)

  • 1. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
    Guindi M; Yazdi HM; Gilliatt MA
    Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
    Kilpatrick SE; Geisinger KR; Loggie BW; Hopkins MB
    Acta Cytol; 1993; 37(6):943-7. PubMed ID: 7504382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
    Johnson DE; Powers CN; Rupp G; Frable WJ
    Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
    Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
    Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
    Ferrandez-Izquierdo A; Llombart-Bosch A
    Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
    Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
    Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas.
    Carrozza MJ; Calafati SA; Edmonds PR
    Acta Cytol; 1991; 35(2):221-4. PubMed ID: 1851357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS; Pomjanski N; Buckstegge B; Böcking A
    Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical presentation of hepatocellular carcinoma.
    UyBarreta V; Mikesh C; Simmons B; Beech DJ
    South Med J; 2000 May; 93(5):516-9. PubMed ID: 10832956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine needle aspiration biopsy cytology of hepatoblastoma.
    Wakely PE; Silverman JF; Geisinger KR; Frable WJ
    Mod Pathol; 1990 Nov; 3(6):688-93. PubMed ID: 2175898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK; Zarbo RJ; Frierson HF; Lee MW
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.